id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
3327468,acac5f38-83d5-4e06-8b7a-7f7ba3a843b3,1T,"THE PETRIZZO GROUP, INC.",305932,DYSAUTONOMIA INTERNATIONAL,2025,first_quarter,MED,"Advocate for NIH research funding for dysautonomia disorders, specifically Postural Orthostatic Tachycardia Syndrome (POTS) and funding to examine the correlation between POTS and Long COVID. Supporting establishment of an infection associated chronic conditions office at the NIH to coordinate research. Asking for continued support for the Autonomic Medicine Section at the NIH.","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",15000,,0,1,2025-02-14T00:23:48-05:00
3327846,098abfe3-f5b9-4594-8d27-66440332ff03,Q1,"AUBURN HEALTH STRATEGIES, LLC",292697,AMERICAN PROFICIENCY INSTITUTE,2025,first_quarter,MED,proficiency testing for clinical laboratories,"Health & Human Services, Dept of (HHS),SENATE",,,0,0,2025-03-31T13:38:50-04:00
3327918,5201f3e4-7dc4-4164-b353-439594056e63,Q1,GABBERT CONSULTING CO LLC,401105309,"CHIPPS, CAFFREY AND DUBILIER, P. S. C.",2025,first_quarter,MED,Supported HR 1463 a bill that restricts funding for FDA's LDT ruling,HOUSE OF REPRESENTATIVES,9000,,0,0,2025-03-31T20:22:36-04:00
3328054,bb835152-1ca1-4ae4-afdb-59c9cffbb047,Q1,"MAGILL ASSOCIATES, LLC",401103511,THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES,2025,first_quarter,MED,FY 2025 and 2026 appropriations for the development of a synthetic vaccine,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2025-04-01T11:43:44-04:00
3328215,169505da-008b-42da-84ca-413f5fabfbde,Q1,RAY C CULVER III,11468,ARKANSAS CHILDREN'S HOSPITAL,2025,first_quarter,MED,"USDA ARS Human Nutrition Research funding in FY2025 Full-Year Continuing Appropriations and Extensions Act, P.L. 119-4, and FY2026 Agriculture Appropriations","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2025-04-01T19:40:55-04:00
3328220,96c1fa48-0e6d-4abc-9568-5c2b42a9ae59,Q1,THE HARRIS FIRM,68376,HOLISTIC INDUSTRIES INC.,2025,first_quarter,MED,Issues pertaining to cannabis CSA scheduling.,"Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE",50000,,0,0,2025-04-01T20:45:35-04:00
3328539,321b12aa-1d40-42ac-b650-110903870be3,Q1,AMERICAN COLLEGE OF CLINICAL PHARMACY,57258,AMERICAN COLLEGE OF CLINICAL PHARMACY,2025,first_quarter,MED,Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,144981,0,0,2025-04-03T09:13:16-04:00
3328545,54b2c416-600f-4e08-b079-13485d7e9601,Q1,MCDERMOTT+ LLC,401103287,VERILY LIFE SCIENCES LLC,2025,first_quarter,MED,"Efforts relating to artificial intelligence, wastewater surveillance, and drug device innovation.","Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2025-04-03T09:24:39-04:00
3328556,f0d657cf-ec27-47e4-beec-36b893040c6a,Q1,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,"ADVANCED MATERIALS AND DEVICES, INC.",2025,first_quarter,MED,Educated key government stakeholders on AMADs products applicable to the military and supported appropriations requests.,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2025-04-03T09:51:36-04:00
3328623,6fe1272d-894a-4392-adeb-597849df91ff,Q1,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,HAZELDEN BETTY FORD FOUNDATION,2025,first_quarter,MED,Educate key government stakeholders on Hazelden Betty Ford Foundation activities in support of substance use and mental health for US Servicemembers and Veterans.,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2025-04-03T10:51:21-04:00
3328857,abf3b5d6-4786-48e0-8f11-eebb8f4d689c,Q1,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,MMV MEDICINES FOR MALARIA VENTURE,2025,first_quarter,MED,The purpose was to increase funding for malaria research in the Department of Defense.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2025-04-04T12:48:24-04:00
3329115,061353ae-f804-482a-a6be-d77a267d4170,Q1,OCAL LOBBYING GROUP,401106825,SAMERA S.A.,2025,first_quarter,MED,Planning for year end project initiative,,,,0,0,2025-04-06T09:09:04-04:00
3329402,94beee11-e2aa-4453-8bb2-3ee0155f366e,Q1,ACADEMY OF NUTRITION AND DIETETICS (FORMERLY AS AMERICAN DIETETIC ASSOCIATION),2241,ACADEMY OF NUTRITION AND DIETETICS (FORMERLY AS AMERICAN DIETETIC ASSOCIATION),2025,first_quarter,MED,Nutrition Research,,,95000,0,0,2025-04-07T13:01:10-04:00
3329429,748bc30b-1de6-47da-9d18-3208b41f221e,Q1,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,AMERICAN SOCIETY FOR RADIATION ONCOLOGY,2025,first_quarter,MED,Discussions regarding patient access to radiation oncology.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES",50000,,0,0,2025-04-07T13:44:24-04:00
3329499,ce2737b5-8bab-4788-82c6-ae098f0ae2ae,Q1,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,THE GENEVA FOUNDATION,2025,first_quarter,MED,Educated key government stakeholders on The Geneva Foundations research and development activities in support of US Service members.,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2025-04-07T14:53:57-04:00
3329501,0e36fe5b-91ed-4921-a2dd-a83dae8137c5,Q1,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,THE REGENTS OF THE UNIVERSITY OF COLORADO OBO UNIVERSITY OF COLORADO ANSCHUTZ,2025,first_quarter,MED,Educated key government stakeholders on the University's medical capabilities in areas applicable to military health and readiness. Supported Defense authorizations and appropriations.,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2025-04-07T14:56:00-04:00
3329504,b769724c-6fa1-439b-be31-f660e4da3559,Q1,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,THE UNIVERSITY OF TEXAS SYSTEM,2025,first_quarter,MED,"Assessing the Systems R&D funding opportunities, designing strategies to pursue funding, and securing funding for research priorities.","HOUSE OF REPRESENTATIVES,SENATE",90000,,0,0,2025-04-07T14:58:55-04:00
3329594,90718524-5710-4e4e-9cd2-d7b80d973af7,Q1,"REPUBLIC CONSULTING, LLC",401016871,IQVIA,2025,first_quarter,MED,Monitor health data budgets and policy.,"Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2025-04-07T16:33:02-04:00
3329612,faf151aa-f701-489b-8f7a-1f6d35167bd1,Q1,CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER,312496,CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER,2025,first_quarter,MED,"vaccines, 340B, cdc reform, nih reform, pediatric research","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office",,38650,0,0,2025-04-07T16:48:26-04:00
3329989,961ed792-15bb-409d-b06e-00b4db507c68,Q1,ACORN CONSULTING,401107972,"THORAGENIX INNOVATIONS, INC.",2025,first_quarter,MED,Advancing study and approval for medical devices,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2025-04-08T14:35:14-04:00
3330156,a5dc9a15-4510-4a8e-b7b2-82eb07d85f21,1T,"COMPASS GOVERNMENT RELATIONS PARTNERS, LLC",401106533,"COALITION FOR INNOVATIVE LABORATORY TESTING, INC.",2025,first_quarter,MED,Matters pertaining to the VALID Act of 2023 (H.R.2369),,,,0,1,2025-04-09T10:34:56-04:00
3330458,fcd44b10-4df2-4c2e-9fa6-a9152eefc6e9,Q1,AMERICAN SOCIETY OF HEMATOLOGY,59171,AMERICAN SOCIETY OF HEMATOLOGY,2025,first_quarter,MED,"Sickle cell disease/trait issues Hematology/oncology treatment issues Hematology/oncology drug research and approval issues General hematology public health and research issues Open access policy for peer reviewed research journals Women's health and research Issues impacting blood supply shortages/safety Issues impacting delivery of bone marrow, peripheral blood, and cord blood Clinical trials regulations and coverage Issues impacting laboratory testing and pediatric reference intervals (PRIs) Issues impacting laboratory developed tests (LDTs) Issues impacting drug shortages FDA guidance impacting hematology Impact of restructuring and reorganization of federal public health and research agencies","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),President of the U.S.,SENATE,White House Office",,30000,0,0,2025-04-09T13:43:02-04:00
3330603,4c5fa772-7db9-4359-8a1e-4d58a78664e3,Q1,"HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.",52925,"HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.",2025,first_quarter,MED,HR 2319/S 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 All provisions This bill requires a review of women and lung cancer.,"HOUSE OF REPRESENTATIVES,SENATE",,60000,0,0,2025-04-09T15:38:26-04:00
3330794,56a79183-96de-470f-8e41-99ba4888ca06,Q1,SQUIRE PATTON BOGGS,30906,"LA MAESTRA FOUNDATION ON BEHALF OF LA MAESTRA FAMILY CLINIC, INC.",2025,first_quarter,MED,Funding support for federally qualified health centers; reauthorization of programs,,20000,,0,0,2025-04-10T10:46:45-04:00
3330961,fc35a166-40c9-46c7-b829-5c1d5603745b,Q1,TROUTMAN STATEGIES,81511,MURAL HEALTH,2025,first_quarter,MED,Issues related to taxing payments and reimbursements to participants in clinical trials. H.R. 7418 the Harley Jacobsen Clinical Trial Participant Income Exemption Act.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2025-04-10T12:51:28-04:00
3331296,d648ec59-94d0-429f-8964-5365f0717722,Q1,"THE LIVINGSTON GROUP, LLC",49635,INNOVATIVE VACCINE TECHNOLOGIES,2025,first_quarter,MED,FY2026 appropriations for the development of a synthetic vaccine,,30000,,0,0,2025-04-10T15:15:21-04:00
3331381,4857d61d-af60-4c51-a772-f46f46cca76c,1A,DARTMOUTH-HITCHCOCK MEDICAL CENTER,40014114,DARTMOUTH-HITCHCOCK MEDICAL CENTER,2025,first_quarter,MED,"Grant management, including funding status",,,10000,0,0,2025-04-10T16:08:05-04:00
3331511,2f00c8e8-f3cf-40b4-9671-4b7f5887d058,Q1,"MASON STREET CONSULTING, LLC",401105150,PERIMETER MEDICAL IMAGING,2025,first_quarter,MED,Advanced Research Projects Agency for Health (ARPA-H).,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2025-04-10T18:24:35-04:00
3331538,ded0cc00-c343-4bf2-9a86-14e7856d7938,Q1,"OLD NORTH STRATEGIES, LLC",401106174,"EXELA PHARMA SCIENCES, LLC",2025,first_quarter,MED,R&D of meds,"HOUSE OF REPRESENTATIVES,SENATE",138000,,0,0,2025-04-10T21:04:23-04:00
3331592,67a86ee7-9708-486b-8b8d-d01f6e1a9d9d,Q1,IMPACT MANAGEMENT GROUP,401104137,ARKANSAS RESEARCH ALLIANCE,2025,first_quarter,MED,On behalf of client support continued and future funding for clinical research programs in Arkansas,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2025-04-11T09:15:46-04:00
3331633,30711921-3c3c-4c70-9407-f2b25364dcd9,Q1,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,"NIRSENSE, LLC (FKA BIONICA LABS)",2025,first_quarter,MED,Educated key government stakeholders on NIRSenses activities and technologies in support of the Armed Forces and support Defense appropriations and authorization requests.,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2025-04-11T09:52:26-04:00
3331640,bdaace22-a6b1-4e44-a324-5342b81d59df,Q1,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,CITY OF HOPE MEDICAL CENTER,2025,first_quarter,MED,Issues related to Medicare/Medicaid reimbursement and clinical research.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2025-04-11T09:56:39-04:00
3331778,8cb74e31-7e6f-45fa-abf9-a7bea96d4531,Q1,AMERICAN ASSOCIATION FOR CANCER RESEARCH,400601833,AMERICAN ASSOCIATION FOR CANCER RESEARCH,2025,first_quarter,MED,"Cancer research generally Increasing diversity in clinical trials Drug approval Pediatric cancer detection, treatment, prevention","HOUSE OF REPRESENTATIVES,SENATE",,100000,0,0,2025-04-11T11:08:03-04:00
3331892,9561a10d-93dc-40cf-99be-0014eb317ba9,Q1,VENABLE LLP,39941,AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE,2025,first_quarter,MED,NIH reform proposals World Neglected Tropical Disease Day,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2025-04-11T12:05:17-04:00
3331977,1184b25e-c0f1-4154-9079-eab2d275859d,Q1,IMPACT MANAGEMENT GROUP,401104137,"CENTRAL ARKANSAS RADIATION THERAPY INSTITUTE, INC.",2025,first_quarter,MED,On behalf of Client support continued and future funding for CARTI in Arkansas,HOUSE OF REPRESENTATIVES,,,0,0,2025-04-11T13:21:27-04:00
3332041,b09bda40-0329-4d40-a6b2-93e650e4bcf4,Q1,IPOLICY SOLUTIONS,401105127,ASSOCIATION FOR MOLECULAR PATHOLOGY,2025,first_quarter,MED,"No bill #: legislation to clarify CLIA FDA Final Rule: Laboratory Developed Tests S.J.Res.82 - A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Food and Drug Administration relating to ""Medical Devices; Laboratory Developed Tests"" HR 1463: Freedom for Laboratory Innovation and Testing Act","HOUSE OF REPRESENTATIVES,SENATE",70500,,0,0,2025-04-11T14:09:53-04:00
3332081,ef6e91cd-e6d4-48bb-8c4f-4012eb1b04d5,Q1,IPOLICY SOLUTIONS,401105127,ASSOCIATION FOR FRONTOTEMPORAL DEGENERATION,2025,first_quarter,MED,Medical research workforce issues Facility and Administrative Costs,"HOUSE OF REPRESENTATIVES,SENATE",45000,,0,0,2025-04-11T14:41:00-04:00
3332460,12408cbc-22a7-4748-9121-dd3c2722966e,Q1,CHAMBER HILL STRATEGIES,400645947,SANFORD HEALTH,2025,first_quarter,MED,"Issues impacting diagnostics including FDA regulation of laboratory developed tests; H.R.2369, VALID Act of 2023","HOUSE OF REPRESENTATIVES,SENATE",80000,,0,0,2025-04-12T18:00:15-04:00
3332462,bdee4922-d6cd-477e-a75b-e4c82cd18eab,Q1,CHAMBER HILL STRATEGIES,400645947,"MAYO COLLABORATIVE SERVICES, INC.",2025,first_quarter,MED,"Issues impacting diagnostics including FDA regulation of laboratory developed tests; H.R.2369, VALID Act of 2023","HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2025-04-12T18:04:45-04:00
3332481,9f6917d2-62f0-4294-b603-0389fd48f242,Q1,HOLLAND & KNIGHT LLP,18466,PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION,2025,first_quarter,MED,"Implementation and reauthorization of the Food and Drug Administration (FDA) over-the-counter (OTC) drug approval process reforms for sunscreen ingredients included in the Coronavirus Aid, Relief, and Economic Security (CARES Act; Public Law 116-136); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the FY 2026 House and Senate appropriations for the Food and Drug Administration; skin cancer prevention for outdoor workers; use of sunscreen in schools to prevent sunburns in children; reauthorization of the Over-the-Counter Monograph User Fee Act (OMUFA); nomination of new HHS and FDA leadership.","HOUSE OF REPRESENTATIVES,SENATE",70000,,0,0,2025-04-13T07:08:47-04:00
3333228,d3bbcbba-6846-4b9b-85e7-0a43dfedcbba,Q1,ALPINE ADVISORS,401106595,"COALITION FOR CANNABIS POLICY, EDUCATION AND REGULATION",2025,first_quarter,MED,Issues pertaining to government-wide federal regulation of cannabis,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2025-04-14T11:11:49-04:00
3333561,24f4a2fa-f9c2-4a0b-b0b8-17356535fce0,Q1,THE MADISON GROUP,284050,"CERBERUS CAPITAL MANAGEMENT, L.P.",2025,first_quarter,MED,Issues related to medical debt,"HOUSE OF REPRESENTATIVES,SENATE",190000,,0,0,2025-04-14T14:08:11-04:00
3333575,b827db9d-487e-454b-8101-ce474cc88b2d,Q1,"UNIVERSITY OF MARYLAND, BALTIMORE (UMB)",401103161,"UNIVERSITY OF MARYLAND, BALTIMORE (UMB)",2025,first_quarter,MED,NONE,,,10000,0,0,2025-04-14T14:15:54-04:00
3334052,2074c8c3-0e30-4ceb-8b87-8001e02ec420,Q1,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,BIONTECH US INC.,2025,first_quarter,MED,Educated policymakers on BioNTech's federally funded research and development activities.,"HOUSE OF REPRESENTATIVES,SENATE",100000,,0,0,2025-04-14T22:55:44-04:00
3334082,14bd3f99-bfd9-4be2-a572-0c522fb5954a,Q1,BALLARD PARTNERS,401104288,BRAIN ANEURYSM FOUNDATION,2025,first_quarter,MED,To promote and advocate for S. 895/HR. 902.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2025-04-15T02:48:40-04:00
3334128,51f9a59d-af35-455a-8cd5-698cc850bb4a,Q1,BALLARD PARTNERS,401104288,EXTHERA MEDICAL CORPORATION,2025,first_quarter,MED,Guidance and advocacy related to procurement approval from the VA and DoD health systems.,"Health & Human Services, Dept of (HHS)",60000,,0,0,2025-04-15T06:57:40-04:00
3334223,a432260e-6e54-4fb8-bac8-47a5955cda81,Q1,FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC),86196,"INTUITIVE SURGICAL, INC.",2025,first_quarter,MED,Lobbying related to health care issues.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2025-04-15T09:08:38-04:00
3334404,a67dc24f-7edf-4bd4-88cb-f4234bf63075,Q1,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,CHILDREN'S NATIONAL MEDICAL CENTER,2025,first_quarter,MED,"Health-related issues including reimbursement, research, public-health & clinical care.","Education, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",50000,,0,0,2025-04-15T09:58:28-04:00
3334715,32cb20f4-bf02-4b64-96c6-8a88d77dd365,Q1,"THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA)",2970,"THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA)",2025,first_quarter,MED,No bill number: Urge NIH to continue funding for therapy research,Natl Institutes of Health (NIH),,189000,0,0,2025-04-15T11:25:34-04:00
3334811,147dccce-e19f-4068-b664-fe3bc1440736,Q1,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,SMITH & NEPHEW,2025,first_quarter,MED,Educated key government stakeholders on Smith+Nephew products applicable to the military and support appropriations requests.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2025-04-15T12:16:38-04:00
3334888,86edf6de-a580-48ea-93f5-d4deb1301342,Q1,"MANATT, PHELPS, AND PHILLIPS",23645,LOMA LINDA UNIVERSITY MEDICAL CENTER,2025,first_quarter,MED,"Healthcare, Legislation Impacting Hospitals, Federal Funding/CPF and CDF",,140000,,0,0,2025-04-15T12:43:39-04:00
3334898,68226b31-1636-44c2-89ba-2d6cfc2a17b1,Q1,"MANATT, PHELPS, AND PHILLIPS",23645,MEDISYS HEALTH NETWORK,2025,first_quarter,MED,Provider Relief and COVID funding and other healthcare issues; Community Project Funding,,40000,,0,0,2025-04-15T12:44:44-04:00
3334916,8561c3a4-f0ab-4783-850e-035f6c1b795f,Q1,MARSHFIELD CLINIC HEALTH SYSTEM,57830,MARSHFIELD CLINIC HEALTH SYSTEM,2025,first_quarter,MED,"NIH support, funding, NIOSH","HOUSE OF REPRESENTATIVES,SENATE",,60000,0,0,2025-04-15T12:46:55-04:00
3335085,bea34585-9897-4a2e-bc38-66d2cf583f8f,Q1,NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH,26557,NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH,2025,first_quarter,MED,Need for continued biomedical research with animal models,"HOUSE OF REPRESENTATIVES,SENATE",,30000,0,0,2025-04-15T13:57:53-04:00
3335869,e8a40b8c-8a27-4b22-b1fd-ed064bf2bd5e,Q1,COVINGTON & BURLING LLP,11195,AMERICAN CLINICAL LABORATORY ASSOCIATION (ACLA),2025,first_quarter,MED,Potential legislation for regulation of laboratory diagnostics; discussion of Food and Drug Administration (FDA) policies related to diagnostics and laboratory regulation.,"HOUSE OF REPRESENTATIVES,SENATE",90000,,0,0,2025-04-15T20:38:35-04:00
3335876,3ba5e283-66db-4a74-a03c-995a21f3f79d,Q1,BALLARD PARTNERS,401104288,"INSIGHTEC, INC.",2025,first_quarter,MED,Guidance on legislation and regulations regarding medical devices; advocacy regarding the use of medical devices at the VA.,"Veterans Affairs, Dept of (VA)",10000,,0,0,2025-04-15T20:43:30-04:00
3335894,f0131c7b-8779-4dfd-93ea-9136f1d625ee,Q1,"THE PETRIZZO GROUP, INC.",305932,SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION,2025,first_quarter,MED,Increased funding for pediatric medical research,"HOUSE OF REPRESENTATIVES,SENATE",90000,,0,0,2025-04-15T20:59:49-04:00
3335899,43c82736-70f0-495a-99b3-f2b892c23de8,Q1,"THE PETRIZZO GROUP, INC.",305932,OMEROS CORPORATION,2025,first_quarter,MED,"Development and execution of initiatives involving multiple Omeros pipeline targets before the U.S. Government, including funding collaborations associated with COVID, Cancer, and addition within the Department of HHS, NIH, BARDA, and the White House. FDA Rare Disease Center of Excellence","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2025-04-15T21:02:47-04:00
3335970,d5258a43-7cfd-4067-a8c2-af5c7c938361,Q1,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,VOCXI HEALTH,2025,first_quarter,MED,Educated policymakers and key government stakeholders on VOCxi Health research and development activities in support of US Service members. Requested appropriations funding in the Defense Appropriations bill.,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2025-04-16T00:59:29-04:00
3336049,2e814b5b-b95a-4a22-aea0-3dbf6b4f95ce,Q1,BALLARD PARTNERS,401104288,LIFESCIENCE LOGISTICS,2025,first_quarter,MED,Government stockpile storage.,"Health & Human Services, Dept of (HHS)",80000,,0,0,2025-04-16T07:08:57-04:00
3336182,7ff4eefb-7a88-4e4b-b900-e978f37e1845,Q1,PARALYZED VETERANS OF AMERICA,30724,PARALYZED VETERANS OF AMERICA,2025,first_quarter,MED,"Discussions: Department of Veterans Affairs, Medical Research Issues Discussions: National Institutes of Health, Medical Research Issues","HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)",,88646,0,0,2025-04-16T09:45:38-04:00
3336262,b533f95c-6638-4a3d-92a4-da39a0cc504d,Q1,"BOLD STRATEGIES, LLC",401104653,PENNINGTON BIOMEDICAL RESEARCH CENTER,2025,first_quarter,MED,Nutrition and obesity research. Appropriations.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2025-04-16T10:08:36-04:00
3336446,49e888f7-4636-4364-8bac-d25ac2ce5da7,1@,"COMPASS GOVERNMENT RELATIONS PARTNERS, LLC",401106533,"COALITION FOR INNOVATIVE LABORATORY TESTING, INC.",2025,first_quarter,MED,Matters pertaining to the VALID Act of 2023 (H.R.2369),,,,0,1,2025-04-16T10:47:33-04:00
3336473,a2046962-2c36-4a73-9b43-4d55ccb78404,Q1,GLAUKOS CORPORATION,401108368,GLAUKOS CORPORATION,2025,first_quarter,MED,Legislation regarding FDA regulation of combination products,,,45000,0,0,2025-04-16T10:55:21-04:00
3336609,2b2e1c86-7625-4851-b873-1240e02115d2,Q1,FORBES-TATE,400976792,"SUPPLY LINE INTERNATIONAL MEDICAL, LLC",2025,first_quarter,MED,"Issues related to drug shortages, specifically, IV fluids.",Food & Drug Administration (FDA),,,0,0,2025-04-16T11:25:16-04:00
3336664,1a03c5d9-aeef-4565-a131-da8aff0508a0,Q1,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,"GINKGO BIOWORKS, INC.",2025,first_quarter,MED,"Educated key government stakeholders on Ginkgo Bioworks capabilities in support of wastewater surveillance, biomanufacturing, and cell engineering; support authorization language and appropriations for Defense and Labor, Health, Human Services and Education.","Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2025-04-16T11:38:07-04:00
3336716,b64803e0-842f-46d2-9cb6-b0175079f88f,Q1,BEN BARNES GROUP LP,5415,HUNTSMAN CORPORATION,2025,first_quarter,MED,CMS Medicare,,10000,,0,0,2025-04-16T11:50:58-04:00
3336766,bd70b9c6-ba5c-4f6c-8806-2bf1b9441785,Q1,"OAK RIDGE ASSOCIATED UNIVERSITIES, INC.",401104196,"OAK RIDGE ASSOCIATED UNIVERSITIES, INC.",2025,first_quarter,MED,FY2024 - 25; Labor H Appropriations; including emergency preparedness issues,"Health & Human Services, Dept of (HHS)",,30000,0,0,2025-04-16T12:00:14-04:00
3336784,7c47007e-9fca-4136-9d0e-198fd8c02dc6,Q1,CURE SMA,401104586,CURE SMA,2025,first_quarter,MED,"medical research in spinal muscular atrophy, National Institutes of Health funding, U.S. Department of Defense peer reviewed research in spinal muscular atrophy","Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,75000,0,0,2025-04-16T12:03:29-04:00
3336850,8dc55539-8bd3-4ba8-a3df-313b57a895b5,Q1,ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC),1466,ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC),2025,first_quarter,MED,"* ADLM conducted a briefing for congressional staff on the impact of the Food and Drug Administration laboratory developed test rule on children's health. * ADLM endorsed the Freedom for Lab Innovation and Testing Act, which would prevent the FDA from using federal funds to implement the LDT rule; the association also initiated a grassroots campaign in support of the bill. * ADLM joined a coalition letter to House and Senate leaders seeking congressional support for getting public health data restored to agency websites. * ADLM released a position statement raising concerns about barriers to children getting laboratory testing.","HOUSE OF REPRESENTATIVES,SENATE",,130000,0,0,2025-04-16T12:24:20-04:00
3336859,1609b792-82d5-4214-b33b-d9df2e0fbc5a,Q1,TRAVERE THERAPEUTICS,401104190,TRAVERE THERAPEUTICS,2025,first_quarter,MED,"HR 1262, S 932 Give Kids a Chance Act to renew PRV program","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,160000,0,0,2025-04-16T12:25:40-04:00
3337047,66c25592-7f5e-4bca-82da-7fd73e64458e,Q1,NATIONAL NURSES UNITED,40021153,NATIONAL NURSES UNITED,2025,first_quarter,MED,"Discussed suggested improvements to Senator Markey's Health Over Wealth Act (have supported in past sessions) Discussed suggestions for potential bill sponsored by Senator Markey to establish regulations on AI clinical decision-making software in health care setting and the right of health care workers to override recommendations that go against their clinical judgement without employer disciplinary action Endorsed/Supported the Reentry Act, sponsored by Rep. Paul Tonko Expressed importance of vaccines and their impact on public health Oppose the nomination of Robert F. Kennedy Jr. for Secretary of the Department of Health and Human Services (HHS) Submitted questions for the record for Senate HELP and Finance Committee confirmation hearing of Robert F. Kennedy Jr. for Secretary of the Department of Health and Human Services (HHS) Oppose the nomination of Russell Vought for Director of the Office of Management and Budget (OMB). Submitted questions for the record for Senate HELP Committee confirmation hearing of Dr. Martin Makary for FDA Commissioner. Support the Workplace Violence Prevention for Health Care and Social Service Workers Act Urged Congress to oppose an extension of the Acute Hospital Care at Home program through CMS and expressed concerns with AI technology used in health care settings. Expressed support for the Congressional Sign on Letter to Protect Medicare Support Medicare for All Act of 2025 Support the VA Employee Fairness Act of 2025 Oppose funding and staff cuts to HHS, VA, and other federal agencies Oppose funding cuts and other changes to Medicaid through the budget reconciliation process. (H.Con.Res.14/ S.Con.Res.7) Support Richard L. Trumka Protecting the Right to Organize Act Submitted questions for the record for Senate HELP Committee confirmation hearing of Dr. Jay Bhattacharya for NIH Director. Submitted questions for the record for Senate Finance Committee confirmation hearing of Dr. Oz for CMS Administrator Submitted questions for the record for Senate HELP Committee confirmation hearing of Dr. Martin Makary for FDA Commissioner","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Occupational Safety & Health Administration (OSHA),Office of Personnel Management (OPM),SENATE",,90000,0,0,2025-04-16T13:26:01-04:00
3337190,2a0e5b3e-ee17-411c-a758-e10d274d8842,Q1,DANA-FARBER CANCER INSTITUTE,401106163,DANA-FARBER CANCER INSTITUTE,2025,first_quarter,MED,"Support policies to remove barriers to clinical trials, promote research generally, address issues in childhood cancer research including 1509/ S 752 the Accelerating Kids Access to Care Act and HR 1262 the Give Kids a Chance Act","HOUSE OF REPRESENTATIVES,SENATE",,77701,0,0,2025-04-16T14:11:03-04:00
3337755,773841bd-c2c8-4483-971d-39d170d69554,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,DEFENSE HEALTH RESEARCH CONSORTIUM,2025,first_quarter,MED,"HR 8774/S 4921, FY25 Defense Appropriations Act and HR 1968, FY25 Full-Year Continuing Appropriations and Extensions Act, Defense Health Research Programs","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2025-04-16T16:05:21-04:00
3337823,0404343d-94fd-4db7-a675-c2eff3ac8a12,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,PANCREATIC CANCER ACTION NETWORK (PANCAN),2025,first_quarter,MED,"HR 8774/S 4921, FY25 Defense Appropriations Act and HR 1968, FY25 Full-Year Continuing Appropriations and Extensions Act; Peer-Reviewed Pancreatic Cancer Researach Program; HR 9029/S 4942, FY25 Labor HHS Education Act; NIH research on pancreatic cancer","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2025-04-16T16:18:36-04:00
3337862,0a04aa1b-7823-4909-a26a-ca7f996363c7,1T,MICHAEL N. MCCARTY LAW OFFICE PLLC,401104300,AMERICAN MEDICAL TECHNOLOGISTS,2025,first_quarter,MED,"Support funding for Centers for Disease Control and Prevention's Environmental Health Laboratory to ""harmonize"" clinical laboratory test results and to establish pediatric reference intervals for diagnostic testing on children.","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,1,2025-04-16T16:21:25-04:00
3337866,6ddb8ff0-a338-4f59-8aea-d8f63916fde7,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,FOUNDATION FOR PERIPHERAL NEUROPATHY,2025,first_quarter,MED,"HR 8774/S 4921, FY25 Defense Appropriations Act and HR 1968, FY25 Full-Year Continuing Appropriations and Extensions Act; DoD funding for peripheral neuropathy research; HR 9029/S 4942, FY25 Labor HHS Education Act; NIH research on peripheral neuropathy","HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2025-04-16T16:21:51-04:00
3337889,2c0b34e1-3256-4dfb-9015-3b3d90833e20,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,TUBEROUS SCLEROSIS ALLIANCE,2025,first_quarter,MED,"HR 8774/S 4921, FY25 Defense Appropriations Act and HR 1968, FY25 Full-Year Continuing Appropriations and Extensions Act; Tuberous Sclerosis Complex Research Program; HR 9029/S 4942, FY25 Labor HHS Education Act; NIH and CDC funding for tuberous sclerosis complex research and surveillance","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2025-04-16T16:26:43-04:00
3337898,464b267e-efc4-41b8-bb06-7acc9d0fe953,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,KIDNEYCAN,2025,first_quarter,MED,"HR 9029/S 4942, FY25 Labor HHS Education Act, kidney cancer research at NIH","HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2025-04-16T16:28:19-04:00
3337916,8c3fe76c-f620-40c2-85da-067e039a2ee0,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,VHL ALLIANCE,2025,first_quarter,MED,"HR 8774/S 4921, FY25 Defense Appropriations Act and HR 1968, FY25 Full-Year Continuing Appropriations and Extensions Act; DoD research on Von Hippel-Lindau syndrome; HR 9029/S 4942, FY25 Labor HHS Education Act; NIH research on Von Hippel-Lindau syndrome","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2025-04-16T16:31:36-04:00
3338249,94f1377c-3b93-4f9b-81b2-0396a96ceca9,Q1,"F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES",18411,F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES,2025,first_quarter,MED,"(MED) Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R.1108 The Diagnostics Testing Preparedness Plan Act. Issues related to the FDA regulation of diagnostics. Clinical Lab Fee Schedule reform and Medicare coverage of FDA approved breakthrough diagnostics and innovative diagnostics","HOUSE OF REPRESENTATIVES,SENATE",,130000,0,0,2025-04-16T17:32:28-04:00
3338465,b13b32b1-17b5-45e6-90c6-4bb0f3a9d96c,Q1,FORBES-TATE,400976792,CSL BEHRING,2025,first_quarter,MED,Issues related to biopharmaceutical pricing; Issues related to plasma and plasma derived therapies; Issues related to the Preserving Life-saving Access to Specialty Medicines in America Act.,"HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2025-04-16T18:59:29-04:00
3338484,2608dad7-4f1c-463d-9c6b-c2cc5208bf5c,Q1,STANFORD UNIVERSITY,36492,STANFORD UNIVERSITY,2025,first_quarter,MED,Policies with regard to indirect cost reimbursement rates at NIH,"HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),SENATE",,150000,0,0,2025-04-16T19:15:01-04:00
3338733,7d0903c7-0d5f-4f00-857d-3a5fa5e66b83,Q1,BALLARD PARTNERS,401104288,"NOVAVAX, INC.",2025,first_quarter,MED,Guidance navigating vaccine policy.,,50000,,0,0,2025-04-17T00:12:09-04:00
3338911,819d7189-ab54-4932-a69d-96da7110e473,Q1,FORBES-TATE,400976792,CALIFORNIA LIFE SCIENCES ASSOCIATION,2025,first_quarter,MED,Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169).,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2025-04-17T08:45:21-04:00
3339107,ee06bd74-1ee3-407c-93d5-bb7fe1c04ef7,Q1,MCCARTHY STRATEGIC SOLUTIONS,300936,"INOTIV, INC.",2025,first_quarter,MED,"Animal research models to biopharmaceuticals, academic and government research for realizing life-saving medications.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2025-04-17T09:40:07-04:00
3339129,6c5c3c64-e7bd-471c-964d-8e86ff112249,Q1,BROYDRICK & ASSOCIATES,7268,"NORTHSTAR RADIOISOTOPES, LLC",2025,first_quarter,MED,"DOE policies and cooperative agreements expansion legislation, Nuclear medicine CMS Reimbursement, NNSA reorganization. Funding for new cooperative agreements. NDAA provisions.","HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2025-04-17T09:43:04-04:00
3339444,35fcd4fa-4aeb-4944-b5bf-5e67a398e8a7,Q1,AMERICAN PHYSICAL THERAPY ASSOCIATION,3093,AMERICAN PHYSICAL THERAPY ASSOCIATION,2025,first_quarter,MED,"NIH Rehab issues APTA role with NIH Traumatic brain injury research Support of work done at CDC Injury Center on elder adult falls, TBI, youth sports concussions NIH Research and Development funding PT role in childhood obesity Relocate TBI State Grant Program to ACL NIDILRR - Rehab research Nomination to NIH Committees Safety of Children in School (Restraint & Seclusion) Falls and Falls Prevention","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,301389,0,0,2025-04-17T10:32:56-04:00
3339601,169b3116-4c6a-4588-887c-31bce7cfc076,Q1,UNIVERSITY OF IOWA,49191,UNIVERSITY OF IOWA,2025,first_quarter,MED,Support for NIH and CDC funding and institute programs Concerns with 15% cap of facilities and administrative cost rate at NIH Proposals related to facilities and administrative costs,"HOUSE OF REPRESENTATIVES,SENATE",,140000,0,0,2025-04-17T10:55:49-04:00
3339902,f90a82c8-0520-4f4d-b3d6-f2061328579d,Q1,"GREENBERG TRAURIG, LLP",16896,AMERICAN SOCIETY INTERVENTIONAL PAIN PHYSICIANS,2025,first_quarter,MED,"Monitoring and outreach related to legislative and administrative action on Medicare reimbursement, telehealth, and related appropriations Monitor federal and legislative activity related to health care of National All Schedules Prescription Electronic Reporting Act (NASPER) (P.L. 109-60). Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Monitor federal and legislative activity related to Medicare Reimbursement","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2025-04-17T11:29:43-04:00
3340033,13d4ef57-1f6f-4c1a-9e8a-40ea79f6b7a7,Q1,BURRELL INTERNATIONAL GROUP LLC,401103483,"BIOFACTURA, INC.",2025,first_quarter,MED,Medical Countermeasure Development for Smallpox and FY26 LHHS Appropriation,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2025-04-17T11:38:41-04:00
3340800,e10eeaec-240a-4e49-a328-92cba96bad4e,Q1,TEAM HALLAHAN LLC,401104228,THE ROOSEVELT GROUP (ON BEHALF OF LSU HEALTH SCIENCES FOUNDATION),2025,first_quarter,MED,"Research and development efforts and FY 26 Appropriations inside the DOD, HHS/NIH, VA. PACT Act Implementation; community project funding for high performance computing center.","Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,,0,0,2025-04-17T13:04:01-04:00
3340875,6e7b1290-edfa-430c-b4ce-1161d68abf56,Q1,COVINGTON & BURLING LLP,11195,RWE ALLIANCE INC.,2025,first_quarter,MED,Real-world health data and analytics policy.,SENATE,30000,,0,0,2025-04-17T13:18:50-04:00
3340955,b804704d-4feb-4636-9540-5a3c8b20244b,1T,FONTENOT HEALTH POLICY LLC,401107703,ORGANIZE DBA ORGANIZE ACTION NETWORK,2025,first_quarter,MED,"Organ Procurement reforms; Revisions to the Outcome Measure Requirements for Organ Procurement Organizations; Final Rule (42 CFR, Part 486); Organ Procurement Organizations Conditions of Coverage; P.L. 118-14 Securing the U.S. Organ Procurement and Transplantation Network Act","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,1,2025-04-17T13:37:36-04:00
3341167,11551530-91a1-4182-99a1-53493a893c75,Q1,THORN RUN PARTNERS,400534596,CONTINUING MEDICAL EDUCATION COALITION,2025,first_quarter,MED,Issues related to provision of continuing medical education.,"HOUSE OF REPRESENTATIVES,SENATE",110000,,0,0,2025-04-17T14:11:11-04:00
3341900,05a138f8-0a59-4fc6-89c9-120b78ffa5f3,Q1,SUSAN B ANTHONY LIST,400935704,SUSAN B ANTHONY LIST,2025,first_quarter,MED,"H.R.2075, S.987 Protecting Life and Integrity in Research Act of 2025; More Opportunity for Moms to Succeed Act; H.R. 685 Support and Value Expectant Moms and Babies Act; Emergency Medical Treatment and Active Labor Act; HOPE with Fertility Services Act; Dismemberment Abortion Ban Act; IVF Issues; H.R.1349 Womens Protection in Telehealth Act; Budget Reconciliation; Administration Personnel; Presidential Administration Actions; Abortion Ballot Measures; Late-term abortion procedures","HOUSE OF REPRESENTATIVES,SENATE",,600000,0,0,2025-04-17T15:24:54-04:00
3342047,463703bd-a458-4903-8fb4-a68c66e15b77,Q1,CASE WESTERN RESERVE UNIVERSITY,8418,CASE WESTERN RESERVE UNIVERSITY,2025,first_quarter,MED,"FY25 & FY26 House and Senate Appropriations. East Palestine Health Impact Monitoring Act of 2025 (HR 1126), NIH Funding, COVID Research, opioid prevention & research, Prion Center, brain health, neurodegeneration research, neuropsychiatry, scope of nursing, nursing research, nursing workforce development programs, telehealth, social determinants of health, maternal and infant health and mortality, Clinical and Translational Sciences Awards (CTSA), ARPA-H, Cancer Research, Foreign Influence Issues.","HOUSE OF REPRESENTATIVES,SENATE",,80000,0,0,2025-04-17T15:36:43-04:00
3342263,12f07a97-08e8-405a-9108-302cfecd7ead,Q1,WINNING STRATEGIES WASHINGTON,50796,DIABETES PATIENT ADVOCACY COALITION,2025,first_quarter,MED,Issues related to treatment of diabetes and support for diabetes patients,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2025-04-17T15:51:00-04:00
3342361,e31589bb-cc8b-4982-a64f-fcb4c98ee2fb,Q1,FOLEY & LARDNER LLP,15042,CARDIAC RMS,2025,first_quarter,MED,Remote Cardiac Monitoring,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2025-04-17T16:00:03-04:00
3342394,2c889bd5-b3b9-4eb0-ae78-691d305111cf,Q1,NELSON MULLINS RILEY & SCARBOROUGH,285871,"ANBEX, INC.",2025,first_quarter,MED,Stockpile potassium iodide to counteract effects of nuclear radiation.,"HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2025-04-17T16:06:39-04:00